Identification of progressive lesions over time is important to monitor the prostate cancer progression in active surveillance. Delta Radiomics, computed as the relative changes of features among scans, provides temporal evolution of features that may indicate clinical changes along time periods. This pilot study aims to develop a framework to identify progressive lesions on two long-term scans in prostate T2WI based on Delta-radiomics. The current results show that four Delta-radiomics features from GLDM and Shape feature groups have potentials to identify progressive lesions compared to other selected reproducible features.
This abstract and the presentation materials are available to members only; a login is required.